Free release
7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate

7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate

CAS No. :375815-87-5MDL No. :MFCD08460603Formula :C17H19N3O6Boiling Point :-Linear Structure Formula :-InChI Key :-M.W :

Sales:Service@apichina.com
CAS No. :375815-87-5 Brand :Qitai
Formula :C17H19N3O6 M.W :361.35

Introduction

CAS No. :375815-87-5 MDL No. :MFCD08460603
Formula : C17H19N3O6 Boiling Point : -
Linear Structure Formula :- InChI Key :-
M.W : 361.35 Pubchem ID :-
Synonyms :
CP 526555-18;Varenicline (tartrate)
Chemical Name :7,8,9,10-Tetrahydro-6H-6,10-methanoazepino[4,5-g]quinoxaline (2R,3R)-2,3-dihydroxysuccinate

Physicochemical Properties

Num. heavy atoms : 26
Num. arom. heavy atoms : 10
Fraction Csp3 : 0.41
Num. rotatable bonds : 3
Num. H-bond acceptors : 9.0
Num. H-bond donors : 5.0
Molar Refractivity : 93.59
TPSA : 152.87 Ų

Pharmacokinetics

GI absorption : Low
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -10.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.91
Log Po/w (XLOGP3) : -3.38
Log Po/w (WLOGP) : -0.7
Log Po/w (MLOGP) : -0.93
Log Po/w (SILICOS-IT) : 2.43
Consensus Log Po/w : -0.33

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 1.0
Muegge : 2.0
Bioavailability Score : 0.11

Water Solubility

Log S (ESOL) : -0.04
Solubility : 331.0 mg/ml ; 0.917 mol/l
Class : Very soluble
Log S (Ali) : 0.75
Solubility : 2010.0 mg/ml ; 5.57 mol/l
Class : Highly soluble
Log S (SILICOS-IT) : -4.31
Solubility : 0.0179 mg/ml ; 0.0000494 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 3.66
Signal Word:Danger Class:9
Precautionary Statements:P201-P264-P280-P301+P330+P331-P312 UN#:3077
Hazard Statements:H302-H361-H372-H410 Packing Group:
GHS Pictogram: